Prophase inflammation, which is commonly seen in malignant tumors, including breast and liver cancer, may induce cancer by causing abnormal activation of the NF-κB signaling pathway (Karin, 2006; Shen and Tergaonkar, 2009). The gene discussed is NFKB1; the disease is cancer.